Antibody to MLN64, a late endosomal cholesterol-binding membrane protein involved in intracellular cholesterol transport – implicated in cancer progression.
| Institute |
|---|
| Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) |
| Cat. #: | 162394 |
|---|---|
| Cancer types: | Breast cancer |
| Research Fields: | Cancer |
| Application: | ELISA, WB, IHC, ICC |
| Target: | MLN64 / STARD3 |
| Reactivity: | Human, mouse |
| Clone: | MLN-2F4 |
| Host: | Mouse |
| Class: | Monoclonal |
| Primary citation: | Moog-Lutz et al., (1997). Int J Cancer. 71(2):183-91. PMID: 9139840 |
| Product description: | Antibody to MLN64, a late endosomal cholesterol-binding membrane protein involved in intracellular cholesterol transport – implicated in cancer progression. |
|---|---|
| Additional notes: | Avoid repeat freezing and thawing cycles. Does not contain any preservative. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1, k |
| Immunogen: | Synthetic peptide coupled to Ovalbumin (C-HSAKPPTHKYVRGENG) corresponding to aa 369-384 of human MLN64. |
| Target background: | Late endosomal cholesterol-binding membrane protein involved in intracellular cholesterol transport and is implicated in cancer progression. |
|---|
| Storage conditions: | -20°C (up to 3 years) |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151022 | Anti-IL12 [1-1A4] |
Key Info
Anti-IL12 [1-1A4]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151024 | Anti-Hairy [1/24] |
Key Info
Anti-Hairy [1/24]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
| 151036 | Anti-ICAM1 [15.2] |
Key Info
Anti-ICAM1 [15.2]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.